Shanghai Henlius CEO Wants To Capitalize On First-Mover Status
Scott Liu Sets Out Ambitions That Go Beyond China
In an exclusive interview with Generics Bulletin, Dr. Scott Liu, co-founder, and CEO of Chinese biosimilars and biologics specialist Shanghai Henlius Biotech, has set out his vision for the firm’s future in China and around the globe.
